– –Maciej Bonuses, a biologist at Penn State University talking to The scientist How the high number of undetected cases makes it difficult to track the spread of viruses using confirmed infections (March 12)
– –Abdul Mannan Baig, a researcher at Aga Khan University in Pakistan, in conversation with The scientist on indications that SARS-CoV-2 can attack the nervous system (March 24th)
– –Kishana Taylor, a postdoctoral fellow in microbiology and molecular genetics at the University of California, Davis, interviewed The scientist on pandemic hiring freezes in the academic sector (March 26)
– –Kathleen Millen, a neuroscientist at Seattle Children’s Hospital Research Institute, in an email to The scientist How pandemic laboratory shutdowns affected the scientific community (March 27)
A cryogenic electron microscope-based visualization of the SARS-CoV-2 spike protein helps researchers understand precise molecular interactions with antibodies.
VISUALIZATION BY RUBEN DIAZ, DUE TO THE WORK BY DAVID VEESLER, UNIVERSITY OF WASHINGTON
– –Anthony Fauci, Director of the US National Institute of Allergy and Infectious Disease, in conversation with CNNSanjay Gupta on the effects of the COVID-19 pandemic on the psyche of his daughters and other Americans (April 1st)
– –Peter Daszak, President of the non-profit EcoHealth Alliance, in conversation with “60 Minutes” about the ongoing politicization of science with regard to the COVID-19 pandemic (May 10)
– –Erica Ollmann sapphires, an immunologist at the La Jolla Institute of Immunology, in conversation with The scientist on the promise of antibody candidates that could prevent SARS-CoV-2 from entering cells (June 2)
– –Jillian Carmichael, a postdoctoral fellow in the laboratory of virologist Benhur Lee at the Icahn School of Medicine on Mount Sinai The scientist on the lack of research results during the pandemic due to the closure of daycare centers and schools (June 25)
– –Nelly Yatich, Epidemiologist in Nairobi, Kenya, in conversation with The scientist the challenges in determining the base reproduction number R0, which describes the initial spread of infection in a fully susceptible population (July 13)
– –Hannah Davis, a Brooklyn-based artist he speaks to The scientist about memory loss, sporadic vision problems, a racing heart, difficulty breathing, insomnia, and various aches and pains she had for months after testing positive for COVID-19 (July 17)
Ravinder Sehgal is holding one of the birds he studied in a location in southwest Cameroon.
Courtesy of RAVINDER SEHGAL
– –A. David Paltiel of the Yale School of Public Health in conversation with UPI via his paper, which indicated that masks, social distancing, and bi-day college student testing could limit the spread of SARS-CoV-2 on campus this fall (July 31st).
– –Ravinder Sehgal, a biologist at San Francisco State University, interviewed The scientist How a pandemic-related university travel ban restricted its field research on infectious diseases (Aug. 20)
– –Miriam Meradwho directs and speaks to the Precision Medicine Institute on Mount Sinai The scientist on the rapid pace of COVID-19-related research this year (September 16)
Rick Bright (center) with Anthony Fauci (left), Director of the National Institute for Allergies and Infectious Diseases (left), and Marilyn Serafini, former President and Co-CEO of the Alliance for Health Reform
– –Patricia García, an investigator of the solidarity process and former Minister of Health of Peru, in conversation with The scientist after the Surgisphere scandal (October 1st)
– An amended whistleblower complaint from agents Rick Bright, an immunologist who stepped down from the National Institutes of Health on October 6
– –Albert Bourla, Chairman and CEO of Pfizer, in conversation with CNBC After the company announced preliminary results of a Phase 3 study of its COVID-19 vaccine, developed in partnership with BioNTech, it suggests it is 90 percent effective at preventing the disease (Nov. 9).